Jaw complications associated with bisphosphonate use in patients with plasma cell dyscrasias.

Abstract

Osteonecrosis of the jaw has been linked with bisphosphonate use in breast cancer and multiple myeloma patients. We report 17 cases of patients with plasma cell dyscrasia being treated with bisphosphonate who developed osteonecrosis/osteomyelitis of the jaw. Seventeen patients evaluated at our institution between 1998 and 2005 are reported. All were being… (More)

Topics

Cite this paper

@article{Thakkar2006JawCA, title={Jaw complications associated with bisphosphonate use in patients with plasma cell dyscrasias.}, author={Snehal Thakkar and Carlos M. Isada and James E. Smith and Mary Ann Karam and Janice Reed and J. Walton Tomford and K. Katarina Englund and Mark G Richmond and Antonella Licata and Craig Hatch and M A Hussein}, journal={Medical oncology}, year={2006}, volume={23 1}, pages={51-6} }